SHIELD THERAPEUTICS PLC - Profile & Financials

CompanyTrack

Accounts Submitted 29 May 2026 Next due 30 Jun 2026 13 days remaining

Confirmation Submitted 4 Sept 2025 Next due 16 Sept 2026 3 months remaining

Net assets £-1M £13M 2024 year on year

Total assets £57M £19M 2024 year on year

Total Liabilities £59M £32M 2024 year on year

Charges 2

2 outstanding

Contact & Details

Contact

Telephone

0800 000 0000

info@example.com

Website

www.example.com

Full company profile for SHIELD THERAPEUTICS PLC (09761509), an active life sciences and medical technology company based in United Kingdom. Incorporated 3 Sept 2015. Other human health activities. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Period 1 Jan → 31 Dec 2024

Type group

Next accounts 31 Dec 2025

Due by 30 Jun 2026 13 days remaining

Balance Sheet & P&L (2013–2024)

Cash in Bank

£7.02M

Decreased by £3.93M (-36%)

Net Assets

-£1.32M

Decreased by £13.12M (-111%)

Total Liabilities

£58.80M

Increased by £32.28M (+122%)

Turnover

£32.28M

Increased by £18.54M (+135%)

Employees

Decreased by 10 (-14%)

Debt Ratio

102%

Increased by 33 (+48%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 31 Dec Year End	2023 31 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

Funding Rounds 3

Investors (1)

Investor Name	Investor Since	Participating Rounds
Investor 1	Dec 2024	IPO

Share Capital

Share allotments and capital structure

28 Allotments 940,935,936 Shares £116.41m Total

Date From	Share Class	Shares Allotted	Amount Raised	Price/Share
20 May 2026	ORDINARY	1,105,654	£17k	£0.015
28 Jan 2026	ORDINARY	421,455	£11k	£0.025
28 Jan 2026	ORDINARY	156,659	£2k	£0.015
29 Dec 2025	ORDINARY	5,556,447	£83k	£0.015
28 Nov 2025	ORDINARY	481,098	£7k	£0.015

Officers

1 active 2 resigned

Show resigned officers

						Status
Maria Fabiana Lacerca-allen	Director	Argentine,american	United States	59	10 May 2021	Active

Shareholders

Shareholders (13)


Aop Orphan Pharmaceuticals Gmbh	27.0%
Hargreaves Lansdown Plc	9.9%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Aop Health International Management Ag

Liechtenstein

Active

Notified 1 Aug 2022

Nature of Control

Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Nestle Sa

Ceased 1 Sept 2022

Ceased

Group Structure

SHIELD THERAPEUTICS PLC Current Company

PHOSPHATE THERAPEUTICS LTD. united kingdom

SHIELD TX (UK) LIMITED united kingdom

Charges

2 outstanding

Properties

0 total

No related properties

Documents

Company Filings

Date	Category	Description
29 May 2026	Accounts	Annual accounts made up to 31 Dec 2025
28 May 2026	Capital	Allotment of shares (GBP 16,042,861.88) on 20 May 2026
20 Feb 2026	Capital	Allotment of shares (GBP 16,026,277.06) on 28 Jan 2026
29 Jan 2026	Capital	Allotment of shares (GBP 16,019,955.24) on 28 Jan 2026
27 Jan 2026	Capital	Allotment of shares (GBP 16,017,605.35) on 29 Dec 2025

29 May 2026 Accounts

Annual accounts made up to 31 Dec 2025

28 May 2026 Capital

Allotment of shares (GBP 16,042,861.88) on 20 May 2026

20 Feb 2026 Capital

Allotment of shares (GBP 16,026,277.06) on 28 Jan 2026

29 Jan 2026 Capital

Allotment of shares (GBP 16,019,955.24) on 28 Jan 2026

27 Jan 2026 Capital

Allotment of shares (GBP 16,017,605.35) on 29 Dec 2025

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2025

2 weeks ago on 29 May 2026

Allotment of shares (GBP 16,042,861.88) on 20 May 2026

2 weeks ago on 28 May 2026

Allotment of shares (GBP 16,026,277.06) on 28 Jan 2026

3 months ago on 20 Feb 2026

Allotment of shares (GBP 16,019,955.24) on 28 Jan 2026

4 months ago on 29 Jan 2026

Allotment of shares (GBP 16,017,605.35) on 29 Dec 2025

4 months ago on 27 Jan 2026